Search results for " market" in Articles / App Notes
Article
Elucidating Biosimilars Characterization
The growth corresponds to a 20% increase from last year’s figures and accounts for approximately 2% of the overall biologics market. Although narrowly focused on only a small number of therapy areas a…
Article
What is process development?
Ultimately, you will need a process that translates to a manufacturing environment, one that is easy to scale up throughout clinical trials and to the market. By the time you reach Phase III in the dr…
Article
Report from the 12th Plasma Product Biotechnology Forum
The Future
The conference ended with a forward-looking session to address global trends in the plasma product market. From the presentations it can be concluded that the market has both a brigh…
Article
Track-and-Trace Progress Benefits Supply-Chain Security Efforts
Dubbing the new market “real-time transportation visibility platforms,” as opposed to track-and-trace technology, the tech market analysts at Gartner predict that, by 2023, half of all global product-…
Article
Remote Monitoring and Big Data Advance Upstream Automation
…, as are solutions that can be rapidly deployed and easily scaled, thus helping manufacturers get to market faster. A key component of those solutions, adds Chris Sandusky, director of automation sol…
Article
The Importance of Process Intensification and PAT for Achieving Real-Time Release
…rease efficiency and thereby reduce the cost of producing drugs and the time it takes to get them to market. Workflows, capital and operating expenses, product quality, and waste production can all b…
Article
Eliminating Residual Impurities Starts with a Strategic Plan
Other factors relate to the testing process itself, according to Lisa Sapp, biopharma market manager with Agilent Technologies. The selected isolation method—precipitation, filtration, centrifugation,…
Article
The Evolving Role of Starting Materials in Cell and Gene Therapy
Based on this forecast, the industry expects cell and gene therapy products to surge in the market and remain a prominent part of the pharmaceutical industry for years to come (2).
FDA has devel…
Article
Biosimilar Quality Requirements
…imilars and marks significant action taken by the agency to help promote competition in the biologic market. In May 2019, the agency published the draft guidance Development of Therapeutic Protein Bi…
Article
Driving Improved Access to Biosimilars
He suggested that biosimilar versions of insulin would be likely to reach the market over the next few years.
Almost a year after FDA formally issued its Biosimilars Action Plan (3), with the c…